Velabs Therapeutics Announces €3 Million Series B Financing to Advance its Functional Antibody Screening Programme Read more
SunGen Announces to Partner with Athenex to Launch Bivalirudin through PIV Challenges in US Read more
Alexion Pharmaceuticals and Minoryx Therapeutics to Present at SMi’s Orphan Drugs & Rare Diseases Event Read more